Elicio Therapeutics Inc. (ELTX)

Elicio Therapeutics Inc. (ELTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $50.5M; returns 1 day -2.1%, 1 week +21.8%, 1 year -80.0%.

Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company dedicated to developing novel immunotherapies for the treatment of high-prevalence cancers.

Groups ELTX belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Oncology
• Immunotherapy
• Healthcare
• Biopharmaceutical
• Life Sciences
• Cancer Therapeutics
• Pancreatic Cancer
• R&D

ELTX financial model: income statement, cash flow and balance sheet